Ilya Sukhanov

First Pavlov State Medical University of St. Petersburg — Russia

Neuroscience · Life Sciences

14h-index1.0kcitations77works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurotransmitter Receptor Influence on Behavior(29), Receptor Mechanisms and Signaling(28), Neuroscience and Neuropharmacology Research(24), Neuroendocrine regulation and behavior(5), Diet and metabolism studies(5)

Publications77 total

XII Всероссийская конференция с международным участием «Актуальные вопросы доклинических и клинических исследований лекарственных средств и клинических испытаний медицинских изделий»
Экспериментальная и клиническая фармакология·2025Open Access
Phosphodiesterase 10A as a Therapeutic Target in Neuropsychopharmacology: A Review
Regulâtornye issledovaniâ i èkspertiza lekarstvennyh sredstv.·2025Open Access
Reversal of the motivational effects of tetrabenazine by NMDA receptor blockade
Neuropharmacology·2024
Rats Lacking the Dopamine Transporter Display Inflexibility in Innate and Learned Behavior
Biomedicines·2024· 9 citedOpen Access
The prospect for repurposing of fonturacetam: antihyperactive and antiapathic actions in rats
Neuroscience Applied·2024Open Access
Tolerance to paradoxical increase in motor activity caused by inhibition of phosphodiesterase 10a in a model of hypodopaminergy
The Scientific Notes of the Pavlov University·2023· 1 citedOpen Access
Discovery of Guanfacine as a Novel TAAR1 Agonist: A Combination Strategy through Molecular Modeling Studies and Biological Assays
Pharmaceuticals·2023· 6 citedOpen Access
Hyperdopaminergia in rats is associated with reverse effort-cost dependent performance
Journal of Psychopharmacology·2023· 4 cited
Развитие толерантности к стимулирующему действию ингибиторов фосфодиэстеразы 10А на двигательную активность
Экспериментальная и клиническая фармакология·2023Open Access
Unlocking the Therapeutic Potential of Ulotaront as a Trace Amine-Associated Receptor 1 Agonist for Neuropsychiatric Disorders
Biomedicines·2023· 16 citedOpen Access
Dopamine Transporter Deficient Rodents: Perspectives and Limitations for Neuroscience
Biomolecules·2023· 19 citedOpen Access
Inhibition of PDE10A in a New Rat Model of Severe Dopamine Depletion Suggests New Approach to Non-Dopamine Parkinson’s Disease Therapy
Biomolecules·2022· 13 citedOpen Access
Discovery of Trace Amine-Associated Receptor 1 (TAAR1) Agonist 2-(5-(4′-Chloro-[1,1′-biphenyl]-4-yl)-4H-1,2,4-triazol-3-yl)ethan-1-amine (LK00764) for the Treatment of Psychotic Disorders
Biomolecules·2022· 11 citedOpen Access
Tolerance to a paradoxical increase in motor activity induced by PDE10A inhibition under hypodopaminergic conditions
2022· 2 cited
Effects of neonatal NMDA-subtype glutamate receptor blockade on behavior of adult male rats
The Scientific Notes of the Pavlov University·2022Open Access
PUBLICATION OF A SCIENTIFIC ARTICLE IN FOR AN ENGLISH-LANGUAGE JOURNAL. PART 6
Nephrology (Saint-Petersburg)·2022Open Access
Associative learning impairments in rats lacking dopamine transporter
The Scientific Notes of the Pavlov University·2022Open Access
The Lack of Dopamine Transporter Is Associated With Conditional Associative Learning Impairments and Striatal Proteomic Changes
Frontiers in Psychiatry·2022· 13 citedOpen Access
Дизайн фармакологического эксперимента. Внедрение принципов ARRIVE в работу исследовательских центров
2022· 2 cited
P.0249 Dopaminergic modulation of effort-cost dependent performance in rats
European Neuropsychopharmacology·2021· 1 cited
page 1 of 4Next →

Frequent Co-authors

Raul R. Gainetdinov(29), A. A. Savchenko(12), Stefano Espinoza(11), Artem Dorotenko(11), Damiana Leo(9), Мария Дорофейкова(7), О. А. Драволина(7), Antonina Dolgorukova(7), Irina Belozertseva(7), Marius C. Hoener(6), Anton Bespalov(6), Edwin Zvartau(6), Evgeniya V. Efimova(5), M. А. Tur(5), Liudmila Mus(4), Fabio Fumagalli(4), T.D. Sotnikova(4), Н. С. Бортников(4), А. С. Герасимов(4), Lucia Caffino(3)